New injection could tame seasonal birch allergy misery
NCT ID NCT07254871
Summary
This study is testing whether an investigational injection called DM-101PX can safely reduce allergy symptoms in adults with birch pollen allergies. About 100 participants will receive either the treatment or a placebo, and researchers will measure changes in their nasal symptoms after a controlled allergen challenge. The goal is to see if this treatment can better control allergy symptoms compared to a dummy injection.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIRCH POLLEN ALLERGY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cliantha Research
Mississauga, Ontario, ON L4W 1A4, Canada
Conditions
Explore the condition pages connected to this study.